Literature DB >> 20830777

Increasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children with cancer.

Ashok Srinivasan1, Steven E Seifried, Liang Zhu, Deo K Srivastava, Rosalie Perkins, Jerry L Shenep, Matthew J Bankowski, Randall T Hayden.   

Abstract

BACKGROUND: Infections with methicillin-resistant Staphylococcus aureus (MRSA), in community-settings, especially with strains carrying the Panton-Valentine Leukocidin (PVL) genes, have increased markedly in recent years. Colonization with S. aureus is a risk factor for infection. However, there are few studies that examine colonization and infection with PVL-positive strains of MRSA in cancer patients. PROCEDURE: The epidemiology of colonization and infection with MRSA was studied in children with cancer during two time periods: 2000/2001 and 2006/2007. PVL genes were screened and spa typing performed on the isolates.
RESULTS: The prevalence of colonization with MRSA increased from 0.6% in 2000/2001 to 2.9% in 2006/2007 (P = 0.0003). MRSA colonization at admission was associated with infection (P < 0.0001; RR 38.32; 95% CI: 23.36-62.84). The prevalence of infection increased from 0.99% in 2000/2001 to 3.78% in 2006-2007 (P = 0.0002). Of the 32 colonized patients, 18 (56%) had infection. None of the 14 colonized but non-infected patients had dual colonization of nares and rectum, while 8 of the 18 infected patients had colonization of both of these sites (P = 0.004). Ten patients (31%) were colonized with PVL-positive strains. Patients colonized with PVL-positive strains were more likely to be colonized both in the nares and rectum (P = 0.005), and more likely to have infection (P = 0.001). Recurrent MRSA infections were seen in 22% of patients.
CONCLUSION: An increasing prevalence of colonization with MRSA was observed in children with cancer at our institution. Colonization with MRSA especially with PVL-positive strains was associated with infection.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830777      PMCID: PMC2965815          DOI: 10.1002/pbc.22815

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  36 in total

1.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization.

Authors:  Susan S Huang; Richard Platt
Journal:  Clin Infect Dis       Date:  2003-01-17       Impact factor: 9.079

3.  Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study.

Authors:  Roy F Chemaly; Ray Y Hachem; Rola N Husni; Boulos Bahna; Georges Abou Rjaili; Georges Abou Rjaili; Alain Waked; Linda Graviss; B Nebiyou Bekele; Jharna N Shah; Issam I Raad
Journal:  Ann Surg Oncol       Date:  2010-02-03       Impact factor: 5.344

4.  A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds.

Authors:  Robert S Daum; Teruyo Ito; Keiichi Hiramatsu; Farid Hussain; Kanokporn Mongkolrattanothai; Mantana Jamklang; Susan Boyle-Vavra
Journal:  J Infect Dis       Date:  2002-10-03       Impact factor: 5.226

5.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

6.  Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children.

Authors:  A L Frank; J F Marcinak; P D Mangat; P C Schreckenberger
Journal:  Pediatr Infect Dis J       Date:  1999-11       Impact factor: 2.129

7.  Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease.

Authors:  Sophie Jarraud; Christophe Mougel; Jean Thioulouse; Gerard Lina; Hélène Meugnier; Françoise Forey; Xavier Nesme; Jerome Etienne; François Vandenesch
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

9.  Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit.

Authors:  Cheryl Squier; John D Rihs; Kathleen J Risa; Asia Sagnimeni; Marilyn M Wagener; Janet Stout; Robert R Muder; Nina Singh
Journal:  Infect Control Hosp Epidemiol       Date:  2002-09       Impact factor: 3.254

10.  Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population.

Authors:  Mari M Nakamura; Kasey L Rohling; Michael Shashaty; Hongzhou Lu; Yi-Wei Tang; Kathryn M Edwards
Journal:  Pediatr Infect Dis J       Date:  2002-10       Impact factor: 2.129

View more
  8 in total

1.  Enterococcus spp. and S. aureus colonization in neutropenic febrile children with cancer.

Authors:  Julia R Spinardi; Rodrigo Berea; Patricia A Orioli; Marina M Gabriele; Alessandra Navarini; Marina T Marques; Milton N Neto; Marcelo J Mimica
Journal:  Germs       Date:  2017-06-01

2.  Interplay of nasal and rectal carriage of Staphylococcus aureus in intensive care unit patients.

Authors:  Julie Gagnaire; Elisabeth Botelho-Nevers; Patricia Martin-Simoes; Jérôme Morel; Fabrice Zéni; Nicolas Maillard; Christophe Mariat; Cyrille H Haddar; Anne Carricajo; Nathalie Fonsale; Florence Grattard; Bruno Pozzetto; Frédéric Laurent; Philippe Berthelot; Paul O Verhoeven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-04       Impact factor: 3.267

3.  Clinical characteristics of pediatric patients hospitalized with methicillin-resistant Staphylococcus aureus in Canadian hospitals from 2008 to 2010.

Authors:  Kirk Ryan Leifso; Denise Gravel; Aboubaker Mounchili; Sherif Kaldas; Nicole Le Saux
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 4.  Staphylococcus aureus - antimicrobial resistance and the immunocompromised child.

Authors:  J Chase McNeil
Journal:  Infect Drug Resist       Date:  2014-05-07       Impact factor: 4.003

Review 5.  Fecal Carriage of Staphylococcus aureus in the Hospital and Community Setting: A Systematic Review.

Authors:  Shantelle Claassen-Weitz; Adebayo O Shittu; Michelle R Ngwarai; Lehana Thabane; Mark P Nicol; Mamadou Kaba
Journal:  Front Microbiol       Date:  2016-05-10       Impact factor: 5.640

6.  The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.

Authors:  Ali Alrstom; Tamim Alsuliman; Nizar Daher; Raed Abouharb
Journal:  Infect Chemother       Date:  2021-01-22

7.  Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center.

Authors:  Miriam A Füller; Stefanie Kampmeier; Anna M Wübbolding; Judith Grönefeld; Almut Kremer; Andreas H Groll
Journal:  Support Care Cancer       Date:  2022-05-19       Impact factor: 3.359

8.  Nasal Carriage Rate, Antimicrobial Susceptibility Pattern, and Associated Factors of Staphylococcus aureus with Special Emphasis on MRSA among Urban and Rural Elementary School Children in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study.

Authors:  Abiye Tigabu; Moges Tiruneh; Feleke Mekonnen
Journal:  Adv Prev Med       Date:  2018-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.